← Evidence map

ArticleBlood cancer journal2015

Romidepsin targets multiple survival signaling pathways in malignant T cells.

B C Valdez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

44 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 26473529